Ellie Carmody

Ellie Carmody

Auto-generated profile, based on publicly available information

Ellie Carmody

Division of Infectious Diseases and Immunology, Department of Medicine, NYU School of Medicine, NYU Langone Medical Center, New York, New York, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2016 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TUTimothy M. Uyeki
Timothy M. Uyeki
BEBobbie Rae Erickson
Bobbie Rae Erickson
SBShelley Brown
Shelley Brown
AMAnita McElroy
Anita McElroy
DCDeborah Cannon
Deborah Cannon
USUte Ströher
Ute Ströher
We investigated the duration of Ebola virus (EBOV) ribonucleic acid (RNA) and infectious EBOV in semen specimens of five Ebola virus disease (EVD) survivors. EBOV RNA and infectious EBOV was detected by real-time RT-PCR and virus culture out to 290 days and 70 days, respectively after EVD onset.

1 January 2018 in Cell Reports
Verified
Journal Article
Open access
SWShannon Whitmer
Shannon Whitmer
JLJason T. Ladner
Jason T. Ladner
MWMichael Wiley
Michael Wiley
KPKetan Patel
Ketan Patel
GDGytis Dudas
Gytis Dudas
USUte Ströher
Ute Ströher
Following cessation of continuous Ebola virus (EBOV) transmission within Western Africa, sporadic EBOV disease (EVD) cases continued to re-emerge beyond the viral incubation period. Epidemiological and genomic evidence strongly suggests that this represented transmission from EVD survivors. To investigate whether persistent infections are characterized by ongoing viral replication, we sequenced EBOV from the semen of nine EVD survivors and a subset of corresponding acute specimens. EBOV evolutionary rates during persistence were either similar to or reduced relative to acute infection rates. Active EBOV replication/transcription continued during convalescence, but decreased over time, consistent with viral persistence rather than viral latency. Patterns of genetic divergence suggest a moderate relaxation of selective constraints within the sGP carboxy-terminal tail during persistent infections, but do not support widespread diversifying selection. Altogether, our data illustrate that EBOV persistence in semen, urine, and aqueous humor is not a quiescent or latent infection.

8 August 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MAMatthew Akiyama
Matthew Akiyama
DCDevin Columbus
Devin Columbus
RMRoss MacDonald
Ross MacDonald
AJAlison O. Jordan
Alison O. Jordan
JSJessie Schwartz
Jessie Schwartz
ECEllie Carmody
Ellie Carmody
Hepatitis C virus (HCV) is a major public health problem in correctional settings. HCV treatment is often not possible in U.S. jails due to short lengths of stay. Linkage to care is crucial in these settings, but competing priorities complicate community healthcare engagement and retention after incarceration. We conducted a single arm clinical trial of a combined transitional care coordination (TCC) and patient navigation intervention and assessed the linkage rate and factors associated with linkage to HCV care after incarceration. During the intervention, 84 participants returned to the community after their index incarceration. Most participants were male and Hispanic, with a history of mental illness and a mean age of 45 years. Of those who returned to the community, 26 (31%) linked to HCV care within a median of 20.5 days; 17 (20%) initiated HCV treatment, 15 (18%) completed treatment, 9 (11%) had a follow-up lab drawn to confirm sustained virologic response (SVR), and 7 (8%) had a documented SVR. Among those with follow-up labs the known SVR rate was (7/9) 78%. Expressing a preference to be linked to the participant’s existing health system, being on methadone prior to incarceration, and feeling that family or a loved one were concerned about the participant’s wellbeing were associated with linkage to HCV care. Reporting drinking alcohol to intoxication prior to incarceration was negatively associated with linkage to HCV care. We demonstrate that an integrated strategy with combined TCC and patient navigation may be effective in achieving timely linkage to HCV care. Additional multicomponent interventions aimed at treatment of substance use disorders and increasing social support could lead to further improvement. Clinicaltrials.gov NCT04036760 July 30th, 2019 (retrospectively registered).

17 May 2016 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HSHari Shankar
Hari Shankar
DBDemetri Blanas
Demetri Blanas
KBKian Bichoupan
Kian Bichoupan
DNDaouda Ndiaye
Daouda Ndiaye
ECEllie Carmody
Ellie Carmody
PPPonni V. Perumalswami
Ponni V. Perumalswami
Background. Sub-Saharan African nations have among the highest rates of chronic hepatitis B virus (HBV) infection worldwide, but little is known about HBV infection in African-born persons in the United States. Methods. From October 2011 to July 2013, community-based HBV screenings were conducted targeting persons originating from Africa in New York City. Persons were identified as currently HBV infected (HBsAg positive) or exposed (HBcAb positive). Results. Overall, 955 persons were screened for HBV; the median age was 45 years (interquartile range, 35–54 years) and 75.5% were men. Of these, 919 persons had no history of liver disease, of whom 9.6% (n = 88) had current HBV infection and 73.9% (n = 679) had exposure. In logistic regression, older age (odds ratio [OR], 0.97; 95% confidence interval [CI], .94–.99; P < .01) and female sex (OR, 0.35; 95% CI, .14–.75; P < .01) were less likely to be associated with HBV infection, whereas having a mother with hepatitis was associated with infection (OR, 18.8; 95% CI, 2.72–164.65; P < .01). HBV exposure was associated with older age (OR, 1.03; 95% CI, 1.01–1.04; P < .01), whereas female sex (OR, 0.46; 95% CI, .33–.66; P < .01) and history of blood transfusion (OR, 0.43; 95% CI, .22–.83; P = .01) were negatively associated. A patient navigator linked 97% of infected persons to care. Eleven persons were recommended for treatment, of whom 9 (82%) started therapy. Three persons were diagnosed with hepatocellular carcinoma on the first screening ultrasound. Conclusions. The high burden of HBV infection among African immigrants in the United States underscores a need for continued screening and linkage to care in this at-risk population.

1 April 2016 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
WAWaridibo E. Allison
Waridibo E. Allison
WCWilliam Chiang
William Chiang
ARAda Rubin
Ada Rubin
LOLauren O'DOnnell
Lauren O'DOnnell
MSMiguel A. Saldivar
Miguel A. Saldivar
ECEllie Carmody
Ellie Carmody

17 May 2021 in Journal of Community Health
Verified
Journal Article
Closed access
PDF file
ECEllie R. Carmody
Ellie R. Carmody
DZDevon Zander
Devon Zander
EKElizabeth J. Klein
Elizabeth J. Klein
MMMark J. Mulligan
Mark J. Mulligan
ACArthur L. Caplan
Arthur L. Caplan